{
  "patient_id": "CASE-015",
  "meds": [
    "Simvastatin",
    "Gemfibrozil"
  ],
  "allergies": [],
  "conditions": [
    "Hyperlipidemia"
  ],
  "labs": [
    {
      "name": "ALT",
      "value": 150,
      "unit": "U/L",
      "date": "2024-05-28"
    },
    {
      "name": "AST",
      "value": 140,
      "unit": "U/L",
      "date": "2024-05-28"
    }
  ],
  "notes": [
    {
      "date": "2024-05-28",
      "author": "Dr. Lipid",
      "content": "Follow up. ALT/AST elevated (150/140).\nPlan: Continue Simvastatin and Gemfibrozil."
    }
  ],
  "ground_truth": [
    {
      "category": "MED_LAB_CONFLICT",
      "severity": "HIGH",
      "key": "Statin-Fibrate Interaction",
      "explanation": "Simvastatin + Gemfibrozil interaction risk (Rhabdo)."
    },
    {
      "category": "MED_LAB_CONFLICT",
      "severity": "HIGH",
      "key": "Liver Injury",
      "explanation": "Continuing hepatotoxic meds despite 3x elevation in LFTs."
    }
  ]
}